New Alzheimer's treatment aims to slow memory loss
Disease control
Not yet recruiting
This study is testing whether a traditional Chinese medicine formulation called MLC901 (NeuroAiD™II) can slow down cognitive decline in people with mild to moderate Alzheimer's disease. About 350 participants will take either MLC901 or a placebo for 12 months to see if the treatm…
Phase: PHASE3 • Sponsor: Moleac Pte Ltd. • Aim: Disease control
Last updated Apr 02, 2026 00:26 UTC